1.
Deucravacitinib in Plaque Psoriasis: Immune Response to and Safety of Pneumococcus and Tetanus Toxoid Vaccines in the POETYK LTE Trial. J of Skin [Internet]. 2025 Mar. 17 [cited 2026 Mar. 9];9(2):s534. Available from: https://skin.dermsquared.com/skin/article/view/3312